share_log

HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $4.5

Benzinga ·  Aug 16, 2023 06:39

HC Wainwright & Co. analyst Ed Arce maintains Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and lowers the price target from $7 to $4.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment